Trial Profile
A Randomized, Double-Blind, Placebo-Controlled Study of Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Subjects With Hyperinsulinemia and Elevated Waist/Hip Ratio
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Metformin (Primary) ; Rosiglitazone (Primary)
- Indications HIV infections; Hyperinsulinaemia; Lipodystrophy
- Focus Pharmacodynamics
- 21 Aug 2013 New trial record